ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 33437802

Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review.

Fiste O and 5 others. Ann Transl Med, 2020. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review. Papers, record 33437802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33437802

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review.
PubMed
Journal
Ann Transl Med
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.48
iCite
Revised in PubMed
2024-09-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fiste OOraianthi
2Liontos MMichael
3Koutsoukos KKonstantinos
4Terpos EEvangelos
5Dimopoulos MAMeletios A
6Zagouri FFlora

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120,624,164Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.Cancer Sci2010https://conductscience.org/library/papers/20624164PubMed
225,220,842Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.Int J Cancer2015https://conductscience.org/library/papers/25220842PubMed
328,187,516Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.Clin Pharmacol Ther2017https://conductscience.org/library/papers/28187516PubMed
431,138,588Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial.Clin Cancer Res2019https://conductscience.org/library/papers/31138588PubMed
529,860,922Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3.J Clin Oncol2018https://conductscience.org/library/papers/29860922PubMed
630,860,573Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial.Ann Oncol2019https://conductscience.org/library/papers/30860573PubMed
722,722,201The landscape of cancer genes and mutational processes in breast cancer.Nature2012https://conductscience.org/library/papers/22722201PubMed
830,867,072An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).J Immunother Cancer2019https://conductscience.org/library/papers/30867072PubMed
931,091,374Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.N Engl J Med2019https://conductscience.org/library/papers/31091374PubMed
1023,484,797Analysis of circulating tumor DNA to monitor metastatic breast cancer.N Engl J Med2013https://conductscience.org/library/papers/23484797PubMed

1 to 10 of 67

See all 67 references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
40,825,169Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS Study.JCO Precis Oncol2025https://conductscience.org/library/papers/40825169PubMed
39,808,248The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer.J Gastrointest Cancer2025https://conductscience.org/library/papers/39808248PubMed
39,148,033Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA.BMC Cancer2024https://conductscience.org/library/papers/39148033PubMed
39,063,972Evolving Management of Breast Cancer in the Era of Predictive Biomarkers and Precision Medicine.J Pers Med2024https://conductscience.org/library/papers/39063972PubMed
38,736,743Personalized circulating tumor DNA response to local radiotherapy in a patient with an early lobular breast cancer: A case report.Oncol Lett2024https://conductscience.org/library/papers/38736743PubMed
36,793,604Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology.Front Oncol2023https://conductscience.org/library/papers/36793604PubMed
35,565,189Current and Developing Liquid Biopsy Techniques for Breast Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/35565189PubMed
35,053,474Role of ctDNA in Breast Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/35053474PubMed
35,046,711Identification of m6A-Associated Gene DST as a Prognostic and Immune-Associated Biomarker in Breast Cancer Patients.Int J Gen Med2022https://conductscience.org/library/papers/35046711PubMed
34,830,863Tumor Suppressive Circular RNA-102450: Development of a Novel Diagnostic Procedure for Lymph Node Metastasis from Oral Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34830863PubMed

1 to 10 of 11

See all 11 cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CYP19A11,588PubTator's text mininghttps://conductscience.org/library/genes/1588NCBI Gene
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22,064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32,065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
EREG2,069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12,099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
ESR22,100PubTator's text mininghttps://conductscience.org/library/genes/2100NCBI Gene
FGFR12,260PubTator's text mininghttps://conductscience.org/library/genes/2260NCBI Gene
FZR151,343PubTator's text mininghttps://conductscience.org/library/genes/51343NCBI Gene

1 to 10 of 19

See all 19 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33437802

GET https://conductscience.org/api/papers/v1/33437802/references?page=2

API referenceFor AI assistants